The Citadel Embolization Device Feasibility Study
Research payments
$1,686,401
Through program year 2025, $1,686,401 in research payments was reported against The Citadel Embolization Device Feasibility Study, across 231 payments, paid by Stryker Corporation.
- Paid by
- Stryker Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $612,728 | 84 |
| 2024 | Research | $429,288 | 51 |
| 2023 | Research | $256,326 | 40 |
| 2022 | Research | $153,024 | 28 |
| 2021 | Research | $180,826 | 18 |
| 2020 | Research | $33,549 | 5 |
| 2019 | Research | $20,660 | 5 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Britton Woodward Knoxville, TN Named on 33 payments
- Ansaar Rai Morgantown, WV Named on 19 payments
- Justin Fraser Lexington, KY Named on 12 payments
- Koji Ebersole Kansas City, KS Named on 11 payments
- Mark Bain Cleveland, OH Named on 10 payments
- Jasmeet Singh Worcester, MA Named on 9 payments
- Benjamin Yim Walnut Creek, CA Named on 9 payments
- Justin Singer Grand Rapids, MI Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.